SQA
VBIV

Simon Quick Advisors’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

Simon Quick Advisors’s Portfolio VBIV Stock Details VBIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-752
Closed -$42K – 602
2019
Q1 		$42K Buy
+752
New +$40.7K 0.02% 224

Other funds holding VBIV

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return
GAI
General American Investors New York $1.69B AUM 40.94% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
FI
Fosun International Hong Kong, China $446M AUM 13.33% 1-Year Est. Return

Simon Quick Advisors's VBIV Position: Q2 2019 in Review

Simon Quick Advisors sold out of VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) in Q2 2019, closing a stake of 752 shares — an estimated $42K sold.

Simon Quick Advisors first reported a position in VBIV in Q1 2019 and held it in 1 quarter. The position peaked at $42K in Q1 2019. 56 funds tracked by Wall St. Rank hold VBIV as of Q2 2019.

  • Simon Quick Advisors reported no remaining VBI Vaccines, Inc. New Common Stock (Canada) position as of Q2 2019 after selling out during the quarter.
  • Simon Quick Advisors sold 752 VBI Vaccines, Inc. New Common Stock (Canada) shares in Q2 2019, an estimated $42K.
  • Simon Quick Advisors first reported a position in VBI Vaccines, Inc. New Common Stock (Canada) in Q1 2019 and held it in 1 quarter.
  • Simon Quick Advisors's VBI Vaccines, Inc. New Common Stock (Canada) position peaked at $42K in Q1 2019.
  • 56 funds tracked by Wall St. Rank held VBI Vaccines, Inc. New Common Stock (Canada) as of Q2 2019.

Based on Simon Quick Advisors's 13F filing for Q2 2019, filed 5 Aug 2019.